by Maria Zannes | Aug 29, 2025 | Articles, News
As published by US Medicine, the Voice of Federal Medicine by Mary Anne Dunkin | Aug 21, 2025 FORT SAM HOUSTON, TX — Lung cancer is the leading cause of cancer deaths in the United States. Early detection is vital, especially for veterans, who face a...
by Maria Zannes | Mar 14, 2025 | Articles, News
As published by 360Dx, March 14, 2025 By Greg Cima NEW YORK – BioAffinity Technologies said that it is cutting costs in its pathology lab and preparing to start a clinical trial for its sputum-based lung cancer test in a bid to expand into a national player in cancer...
by Maria Zannes | Mar 7, 2025 | Articles, News
As published in the San Antonio Business Journal, March 7, 2025 By W. Scott Bailey – Senior Reporter BioAffinity Technologies Inc., one of San Antonio’s more promising early-stage biotech companies, is making tactical changes to improve its financial performance and...
by Maria Zannes | Nov 8, 2024 | Articles, News
The Alamo City biotech has secured a key win in Japan that could make it a key player in a nearly billion-dollar industry. As published in the San Antonio Business Journal By W. Scott Bailey – Senior Reporter, San Antonio Business Journal BioAffinity Technologies Inc....
by Maria Zannes | Oct 16, 2024 | Articles, News
As published in Mergermarket By Deborah Balshem and Jeff Sheban Summary • Medicare reimbursement providing tailwinds • Expansion into government market imminent • Analyst sees labs chains among potential buyers bioAffinity Technologies [NASDAQ:BIAF], a healthcare...
by Maria Zannes | Oct 13, 2024 | Articles, News
With a San Antonio biotech firm’s test, your phlegm could help save you from cancer. As published by the San Antonio Express-News By Brandon Lingle, Staff Writer The screening method developed by bio Affinity Technologies Inc. uses Al-aided computer analysis...